Literature DB >> 19874455

Coronary atherosclerosis and cardiovascular mortality in hemophilia.

C J Foley, L Nichols, K Jeong, C G Moore, M V Ragni.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19874455      PMCID： PMC2881951          DOI： 10.1111/j.1538-7836.2009.03669.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  21 in total

1.  Risk factors and early extracoronary atherosclerotic plaques detected by three-site ultrasound imaging in hypercholesterolemic men. Prévention Cardio-vasculaire en Médecine du Travail METRA Group.

Authors:  P Giral; I Pithois-Merli; V Filitti; J Levenson; M C Plainfosse; C Mainardi; A C Simon
Journal:  Arch Intern Med       Date:  1991-05

2.  Intrinsic pathway of blood coagulation contributes to thrombogenicity of atherosclerotic plaque.

Authors:  Natalya M Ananyeva; Diana V Kouiavskaia; Midori Shima; Evgueni L Saenko
Journal:  Blood       Date:  2002-06-15       Impact factor: 22.113

3.  Hemophilia A, von Willebrand disease, and atherosclerosis of abdominal aorta and leg arteries: factor VIII and von Willebrand factor defects appear to protect abdominal aorta and leg arteries from atherosclerosis.

Authors:  F Bilora; V Boccioletti; E Zanon; F Petrobelli; A Girolami
Journal:  Clin Appl Thromb Hemost       Date:  2001-10       Impact factor: 2.389

4.  Haemophilia protects against ischaemic heart disease: a study of risk factors.

Authors:  F R Rosendaal; E Briët; J Stibbe; G van Herpen; J A Leuven; A Hofman; J P Vandenbroucke
Journal:  Br J Haematol       Date:  1990-08       Impact factor: 6.998

5.  Decreased coagulability has no clinically relevant effect on atherogenesis: observations in individuals with a hereditary bleeding tendency.

Authors:  A Srámek; J H Reiber; W B Gerrits; F R Rosendaal
Journal:  Circulation       Date:  2001-08-14       Impact factor: 29.690

6.  Do hemophilia A and von Willebrand disease protect against carotid atherosclerosis? A comparative study between coagulopathics and normal subjects by means of carotid echo-color Doppler scan.

Authors:  F Bilora; C Dei Rossi; B Girolami; A Casonato; E Zanon; A Bertomoro; A Girolami
Journal:  Clin Appl Thromb Hemost       Date:  1999-10       Impact factor: 2.389

7.  Patients with type 3 severe von Willebrand disease are not protected against atherosclerosis: results from a multicenter study in 47 patients.

Authors:  A Srámek; P Bucciarelli; A B Federici; P M Mannucci; V De Rosa; G Castaman; M Morfini; M G Mazzucconi; A Rocino; M Schiavoni; F A Scaraggi; J H C Reiber; F R Rosendaal
Journal:  Circulation       Date:  2004-02-17       Impact factor: 29.690

8.  Acquired immunodeficiency syndrome-associated non-Hodgkin's lymphomas and other malignancies in patients with hemophilia.

Authors:  M V Ragni; S H Belle; R A Jaffe; S L Duerstein; D C Bass; C W McMillan; E W Lovrien; L M Aledort; C T Kisker; S P Stabler
Journal:  Blood       Date:  1993-04-01       Impact factor: 22.113

9.  Type IIb von Willebrand disease: role of qualitative defects in atherosclerosis and endothelial dysfunction.

Authors:  Franca Bilora; Ezio Zanon; Alessandra Casonato; Antonella Bertomoro; Francesco Petrobelli; Monica Cavraro; Enrico Campagnolo; Antonio Girolami
Journal:  Clin Appl Thromb Hemost       Date:  2007-10       Impact factor: 2.389

10.  Decreased mortality of ischaemic heart disease among carriers of haemophilia.

Authors:  A Srámek; M Kriek; F R Rosendaal
Journal:  Lancet       Date:  2003-08-02       Impact factor: 79.321
View more
  13 in total

1.  Rationale for a randomized controlled trial comparing two prophylaxis regimens in adults with severe hemophilia A: the Hemophilia Adult Prophylaxis Trial.

Authors:  Margaret V Ragni
Journal:  Expert Rev Hematol       Date:  2011-10       Impact factor: 2.929

2.  Atherosclerotic heart disease: prevalence and risk factors in hospitalized men with haemophilia A.

Authors:  M V Ragni; C G Moore
Journal:  Haemophilia       Date:  2011-03-04       Impact factor: 4.287

Review 3.  How I treat patients with inherited bleeding disorders who need anticoagulant therapy.

Authors:  Karlyn Martin; Nigel S Key
Journal:  Blood       Date:  2016-04-22       Impact factor: 22.113

4.  AKAP150 participates in calcineurin/NFAT activation during the down-regulation of voltage-gated K(+) currents in ventricular myocytes following myocardial infarction.

Authors:  Madeline Nieves-Cintrón; Dinesh Hirenallur-Shanthappa; Patrick J Nygren; Simon A Hinke; Mark L Dell'Acqua; Lorene K Langeberg; Manuel Navedo; Luis F Santana; John D Scott
Journal:  Cell Signal       Date:  2015-12-24       Impact factor: 4.315

Review 5.  Management of Hemophilia in Older Patients.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Drugs Aging       Date:  2017-12       Impact factor: 3.923

6.  Risk factors for cardiovascular disease in children and young adults with haemophilia.

Authors:  Jacqueline Limjoco; Courtney D Thornburg
Journal:  Haemophilia       Date:  2018-07-13       Impact factor: 4.287

7.  Prevalence and risk factors for hypertension in hemophilia.

Authors:  Annette von Drygalski; Nicholas A Kolaitis; Ricki Bettencourt; Jaclyn Bergstrom; R Kruse-Jarres; Doris V Quon; Christina Wassel; Ming C Li; Jill Waalen; Darlene J Elias; Laurent O Mosnier; Matthew Allison
Journal:  Hypertension       Date:  2013-04-29       Impact factor: 10.190

8.  A cross-sectional analysis of cardiovascular disease in the hemophilia population.

Authors:  Suman L Sood; Dunlei Cheng; Margaret Ragni; Craig M Kessler; Doris Quon; Amy D Shapiro; Nigel S Key; Marilyn J Manco-Johnson; Adam Cuker; Christine Kempton; Tzu-Fei Wang; M Elaine Eyster; Philip Kuriakose; Annette von Drygalski; Joan Cox Gill; Allison Wheeler; Peter Kouides; Miguel A Escobar; Cindy Leissinger; Sarah Galdzicka; Marshall Corson; Crystal Watson; Barbara A Konkle
Journal:  Blood Adv       Date:  2018-06-12

9.  Porcine and canine von Willebrand factor and von Willebrand disease: hemostasis, thrombosis, and atherosclerosis studies.

Authors:  Timothy C Nichols; Dwight A Bellinger; Elizabeth P Merricks; Robin A Raymer; Mark T Kloos; Natalie Defriess; Margaret V Ragni; Thomas R Griggs
Journal:  Thrombosis       Date:  2011-02-07

Review 10.  Consensus review of the treatment of cardiovascular disease in people with hemophilia A and B.

Authors:  Victor A Ferraris; Leonard I Boral; Alice J Cohen; Susan S Smyth; Gilbert C White
Journal:  Cardiol Rev       Date:  2015 Mar-Apr       Impact factor: 2.644
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.